• Title/Summary/Keyword: 악성 신경초종

Search Result 25, Processing Time 0.025 seconds

Plexiform Neurilemmoma Unassociated with Neurofibromatosis - 2 Cases Report - (신경섬유종증의 동반이 없는 총상 신경초종 - 2 례 보고 -)

  • Lee, Kee-Haeng;Kim, Youn-Soo;Jeong, Chang-Hoon;Sung, Mi-Sook;Kim, Jean-A;Choi, Seung-Woog;Kim, Hyoung-Min
    • The Journal of the Korean bone and joint tumor society
    • /
    • v.11 no.1
    • /
    • pp.82-87
    • /
    • 2005
  • Both neurilemmoma and neurofibroma are originated from Schwann cell. Plexiform tumor was mostly neurofibroma but Neurilemmoma which has plexiform is extremely rare. So it is important to differentiate plexiform neurilemmoma from plexiform neurofibroma, because plexiform neurilemmoma appears to have neither a significant association with neurofibromatosis nor a propensity for malignant transformation. We report two cases of plexiform neurilemmoma involving the left arm and right foot.

  • PDF

En Bloc Resection of a Thoracic Outlet for a Recurred Malignant Schwannoma of the Brachial Plexus - A case report - (상완신경총에 재발한 악성 신경초종에 대한 흉곽출구의 광범위 구역절제술 치험 - 1예 보고 -)

  • Kim, Young-Kyu;Park, Chin-Su;Son, Bong-Su;Kim, Yeong-Dae
    • Journal of Chest Surgery
    • /
    • v.40 no.10
    • /
    • pp.715-718
    • /
    • 2007
  • Neurogenic tumors of the brachial plexus are rare. An malignant schwannoma originates from the schwan cells or nerve sheath cells. Occasionally, schwannomas are associated with Von Rechlinghausen's disease, but this is rare. We were recently presented with a thirty-five year old female patient with a history of pulmonary tuberculosis about ten years prior. The patient also presented with a mass that has been slowly growing for one year. Onset of pain occurred six months after the tumor began to grow. The mass was $5{\times}7cm$ in size. The patient underwent on bloc resection of the tumor as the mass recurred twice in spite of postoperative radiotherapy.

A Case of Malignant Peripheral Nerve Sheath Tumor with Hypopharyngeal Cancer (하인두암과 동반된 경부의 악성 말초 신경초종 1예)

  • Lim, Sang-Ho;Lee, Kyung-Seok;Yang, Yoon-Soo;Hong, Ki-Hwan
    • Korean Journal of Head & Neck Oncology
    • /
    • v.28 no.1
    • /
    • pp.37-41
    • /
    • 2012
  • The malignant peripheral nerve sheath tumor(MPNST) is an extremely rare soft tissue sarcoma of ectomesenchyme also known as malignant schwannoma or malignant neurilemoma. It is a highly malignant sarcoma, which is locally invasive, frequently leading to multiple recurrences and eventual metastatic spread. The peak incidence of this disease is known to arise in the seventh decades. In human body, trunk and extremities are the most commonly involved sites, and only 8-14% of all lesions appear in head and neck region. Because immunohistochemical staining is essential in final diagnosis. The authors report a case of malignant peripheral nerve sheath tumor in neck with hypopharyngeal cancer simultaneously on a review of the literature.

Diagnosis & Surgical Treatment of Neurilemmoma (신경초종의 진단과 수술적 치료)

  • Suh, Jeung-Tak;Park, Byung-Guk;Yoo, Chong-Il
    • The Journal of the Korean bone and joint tumor society
    • /
    • v.5 no.1
    • /
    • pp.44-50
    • /
    • 1999
  • Neurilemmoma is a benign encapsulated nerve sheath tumor originated from peripheral nerve. Previously its preoperative diagnosis had mainly depended on the history, physical examination, electrodiagnostic test, ultrasonography, bone scan. But only with these diagnostic modalities, exact preoperative diagnosis was nearly impossible. Therefore operation was performed under the impression of lipoma or just simple soft tissue tumor. Recently, the advent of magnetic resonance imaging(MRI) has made it easier to diagnose neurilemoma before surgery. MRI also helps to determine the extent of lesion and operative procedures. We performed marginal excision in 24 cases, evaluated those cases with respect to the sex, age, location, chief complaint, duration of illness, preoperative diagnosis, involved nerve, imaging studies, size of mass, complication, duration of follow-up and report with review of the literature.

  • PDF

SOLITARY NEUROFIBROMA OF THE CHIN (이부에 발생한 신경섬유종)

  • Chang, Se-Hong;Ann, Jae-Jynn;Jeong, Min-Won
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • v.11 no.2
    • /
    • pp.81-86
    • /
    • 1989
  • Tumors originated from peripheral nerve tissues are neurofibroma, neurilemoma, plexiform neurofibroma, malignant schwannoma, and granular cell tumor. Neurofibromas seem to occur in two forms : The first one is circumscribed solitary neurofibroma and the second group is neurofibromatosis or Von Recklinghausen's disease, which is a congenital and familial disease, presenting abnormalities of the skin, nerve system, bones and soft tissue. A solitary neurofibroma is a benign, relatively circumscribed, noncapsulated tumor which often presents in the skin and subcutaneous tissue as a soft sessile or pedunculated mass. It may occur anywhere in the head and neck, but the common site of the occurrence is the tongue, buccal mucosa, palate in frequency. Since solitary neurofibroma is a relatively radioresistant and its recurrence rate seem to be low, the treatment of choice is surgical excision. The author would like to present a case of unusually large solitary neurofibroma occured in the chin, which was successfully treated with surgical excision and reconstructed using deltopectoral flap and tongue flap.

  • PDF

A Case of Malignant Triton Tumor on Supraclavicular Area (쇄골 상부에 발생한 악성 Triton 종양 1예)

  • Lim, Sang Ho;Park, Hee Tack;Hong, Ki Hwan
    • Korean Journal of Head & Neck Oncology
    • /
    • v.29 no.2
    • /
    • pp.54-57
    • /
    • 2013
  • Malignant triton tumor(MTT) is a rare type of malignant peripheral nerve sheath tumor(MPNST) with focal rhabdomyoblastic differentiation. MTT constitutes about 5% of all MPNSTs and described the first case of a MTT in a patient with Von Recklinghausen disease by Masson in 1932. MTT is commonly seen in the head, neck, extremities and trunk. It can occur in sporadic form or over a setting of neurofibromatosis-1(NF-1). The diagnosis can be confirmed based on morphologic grounds supported by an immunostain such as S-100 protein. Desmin, myo-D1 and myogenin are immunostains positive for rhabdomyoblasts. MTT has an aggressive biological behavior so prognosis of this rare and highly malignant tumor is poor and optimal treatment remains unclear. But modern treatment consisted of radical excision and postoperative radiotherapy has improved the prognosis of such cases.

Schwannoma of the Extremities (사지에 발생한 신경초종)

  • Bahk, Won-Jong;Rhee, Seung-Koo;Kang, Yong-Koo;Lee, An-Hi
    • The Journal of the Korean bone and joint tumor society
    • /
    • v.9 no.2
    • /
    • pp.148-154
    • /
    • 2003
  • Purpose: To correlate the significant MRI findings and histologic features of the Schwannoma of the extremities and to review the clinical characteristic and the result of the surgical enucleation. Materials and Methods: 67 patients with pathologically proven Schwannoma of the extremities, who were surgically treated at our institutes between January 1996 and June 2002, were selected for this study. The clinical records, EMG, MRI and histologic findings were reviewed. Age of the patients ranged from 8 to 75 years with average of 44.7 years. Mean follow-up period was 9.7 months with raging from 3 months to 46 months. Results: On MRI, Schwannoma shows a well-demarcated fusiform mass with a low to intermediate signal intensity on T1-weighted images and high signal intensity on T2-weighted images, which is connected to parent nerve. A target pattern with peripheral hyperintensive rim and central low intensity on T2-weighted images was seen in 6 cases (15%), and fasciculation pattern with inhomogenous intensity in the hyperintensity on T2-weighted images was observed in 24 cases (62%). Various degree of cystic degeneration was discovered in 25 cases (64%). Postoperative complications include tingling sense or radiating pain in 5 patients, paresthesia in 2 patients, nerve palsy in 2 patients, but all of the complications were recovered during followup period. There were no local recurrence or malignant change. Conclusion: MRI demonstrates characteristic findings of Schwannoma, and very useful tool for preoperative diagnosis and planning of surgery. Exact preoperative diagnosis and meticulous enucleation are enough option of treatment.

  • PDF

A Case of Early Malignant Change from Neurofibroma to Malignant Peripheral Nerve Sheath Tumor (제1형 신경섬유종증, 신경섬유종, 악성 말초신경초종)

  • Poo Reum Kang;Yeong Joon Kim;Sun Ju Oh;Hyoung Shin Lee
    • Korean Journal of Head & Neck Oncology
    • /
    • v.39 no.2
    • /
    • pp.45-48
    • /
    • 2023
  • Malignant peripheral nerve sheath tumor (MPNST) is one of the soft tissue sarcoma believed to originate from neural crest cells. The patients with neurofibromatosis type I (NF1) have about 8-13% of the lifetime risk of the malignant transformation. Neurofibroma on patients with NF1 can be surgically resected and has good prognosis if approach to the tumor is possible. We experienced a case of a 50-year-old woman with NF who had incompletely resected neurofibroma, which presented a rapid malignant transformation to MPNST, 3 months after the first surgery. We reported this case with a brief review of literature.

Clinical Review of Primary Chest Wall Tumors (흉벽에 발생한 원발성 종양에 대한 고찰)

  • 백효채;강정한;최성실;정경영
    • Journal of Chest Surgery
    • /
    • v.36 no.3
    • /
    • pp.175-181
    • /
    • 2003
  • Primary chest wall tumors originate from soft tissue, bone or cartilage of the chest wall and it comprises 1∼2% of all primary tumors. Resection of tumor is often indicated for chronic ulceration or pain, and long-term survival might be achieved after surgery depending on the histology and the surgical procedure. Material and Method: Retrospective study of 125 primary chest wall tumors (86 benign, 39 malignant) operated between Sep. 1976 to Mar 2001 were reviewed and their clinical outcomes were analyzed. Follow-up data were collected at the outpatient clinic. Result: All patients with benign tumors were treated by excision without recurrence or death, and most malignancies were treated by wide resection. Malignant fibrous histiocytoma and chondrosarcoma constituted 46.2% of the malignant neoplasm. There was no operative death. The overall 3-year survival for patients with primary malignant neoplasm was 76.0%, and the 10-year survival was 60.5%. All deaths were disease-related and the tumor recurred in 11 patients. There was no significant difference in survival between patients with resection margins less than 4 cm and those with resection margins greater than 4 cm. Conclusion: Chest wall resection offers excellent results for benign chest wall tumors and substantial long-term survival for malignant diseases. Safe resection margin of 4 cm or more did not correlate with the survival rate although the tumor recurrence correlated with poor survival.